Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moschos

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Current Problems in Cancer|April 10, 2022
Theragnostic significance of tumor-infiltrating lymphocytes and Ki67 in BRAFV600-mutant metastatic melanoma (BRIM-3 trial)Paul B Googe, Stamatios Theocharis, Alexandros Pergaris, et al.
Digestive Surgery|June 2, 2007
Inflammatory fibroid polyp or Vanek's tumourD Paikos, J Moschos, D Tzilves, et al.
Minerva Gastroenterologica E Dietologica|February 27, 2008
Evidence for the ''paradox'' association between hypertensive lower esophageal sphincter and gastroesophageal reflux diseaseG Kouklakis, J Moschos, D Paikos, et al.
Minerva Gastroenterologica E Dietologica|February 27, 2008
Synchronous occurrence of a primary colon adenocarcinoma and a gastric stromal tumor. A case reportD Tzilves, J Moschos, D Paikos, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 11, 2011
Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cellsJeffrey L Wong, Robbie B Mailliard, Stergios J Moschos, et al.
Oncology|December 4, 2019
Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution ExperienceGeorgia Sofia Karachaliou, Fatih Ayvali, Frances A Collichio, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2012
Safety and immunogenicity of vaccination with MART-1 (26-35, 27L), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) in adjuvant with PF-3512676 and GM-CSF in metastatic melanomaAhmad A Tarhini, Siyang Leng, Stergios J Moschos, et al.
Diabetes|December 25, 2003
Responsiveness to peripherally administered melanocortins in lean and obese miceSusann Blüher, Mary Ziotopoulou, John W Bullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responsesStergios J Moschos, Howard D Edington, Stephanie R Land, et al.
Annals of Hepatology|February 14, 2007
Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazoleG Kouklakis, A Mpoumponaris, P Zezos, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Current Problems in Cancer|April 10, 2022
Theragnostic significance of tumor-infiltrating lymphocytes and Ki67 in BRAFV600-mutant metastatic melanoma (BRIM-3 trial)Paul B Googe, Stamatios Theocharis, Alexandros Pergaris, et al.
Digestive Surgery|June 2, 2007
Inflammatory fibroid polyp or Vanek's tumourD Paikos, J Moschos, D Tzilves, et al.
Minerva Gastroenterologica E Dietologica|February 27, 2008
Evidence for the ''paradox'' association between hypertensive lower esophageal sphincter and gastroesophageal reflux diseaseG Kouklakis, J Moschos, D Paikos, et al.
Minerva Gastroenterologica E Dietologica|February 27, 2008
Synchronous occurrence of a primary colon adenocarcinoma and a gastric stromal tumor. A case reportD Tzilves, J Moschos, D Paikos, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 11, 2011
Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cellsJeffrey L Wong, Robbie B Mailliard, Stergios J Moschos, et al.
Oncology|December 4, 2019
Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution ExperienceGeorgia Sofia Karachaliou, Fatih Ayvali, Frances A Collichio, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2012
Safety and immunogenicity of vaccination with MART-1 (26-35, 27L), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) in adjuvant with PF-3512676 and GM-CSF in metastatic melanomaAhmad A Tarhini, Siyang Leng, Stergios J Moschos, et al.
Diabetes|December 25, 2003
Responsiveness to peripherally administered melanocortins in lean and obese miceSusann Blüher, Mary Ziotopoulou, John W Bullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responsesStergios J Moschos, Howard D Edington, Stephanie R Land, et al.
Annals of Hepatology|February 14, 2007
Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazoleG Kouklakis, A Mpoumponaris, P Zezos, et al.
Pageof 9